Vanguard Discloses Position in Mural Oncology

The Vanguard Group, Inc. has issued a disclosure concerning its interests in Mural Oncology plc, adhering to Rule 8.3 of the Irish Takeover Panel Act 1997. The disclosure indicates Vanguard holds 772,611 ordinary shares in Mural Oncology, representing a 4.47% interest.

No cash-settled derivatives or stock-settled derivatives were reported. Notably, Vanguard recently purchased 84,442 shares at $2.49 per share and sold 84,490 shares at the same price. This activity underscores Vanguard's consistent engagement with Mural Oncology’s securities.

Additionally, Vanguard confirmed no indemnity or other dealing arrangements in relation to the securities. No agreements or understandings concerning options or derivatives were disclosed. This comprehensive declaration maintains transparency in Vanguard's financial dealings concerning Mural Oncology.